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Abstract. The development of software tools supporting physicians in the treatment of comorbid 
patients is a challenging goal and a “hot topic” in Medical Informatics and Artificial Intelligence. 
Computer Interpretable Guidelines (CIGs) are consolidated tools to support physicians with evidence-
based recommendations in the treatment of patients affected by a specific disease. However, the 
applications of two or more CIGs on comorbid patients is critical, since dangerous interactions 
between actions from different CIGs may arise. GLARE-SSCPM is the first tool supporting, in an 
integrated way, (i) the knowledge-based detection of interactions, (ii) the management of the 
interactions, and (iii) the final “merge” of (part of) the CIGs operating on the patient. GLARE-SSCPM 
is characterized by being very supportive to physicians, providing them support for focusing, 
interaction detection, and for an “hypothesize and test” approach to manage the detected interactions. 
To achieve such goals, it provides advanced Artificial Intelligence techniques. Preliminary tests in the 
educational context, within the RoPHS project, have provided encouraging results.   
 




Comorbidities are, in the medical context, the co-occurrence in the same patient of two or more 
different diseases. In the last 20 years, Clinical Practice Guidelines (CPGs) have emerged in the 
Medical area as the major tool to promote evidence-based medicine, supporting quality, 
standardization, and optimization of the clinical treatments. CPGs are “systematically developed 
statements to assist practitioner and patient decisions about appropriate health care in specific 
clinical circumstances” [1]. Thousands of CPGs have been devised in the last few years. For instance, 
the Guideline International Network, which groups 103 organizations from all the continents, provides 
a library of more than 6000 CPGs.  Recent research has shown that the development of computer-
based approaches to acquire, represent, execute and reason with Computer-Interpretable Guidelines 
(CIGs henceforth) provides major advantages, and several CIG systems have been developed in the 
last twenty years, (see the surveys [2], [3]). 
CPGs provide evidence-based information of interventions, but only on individual pathologies. The 
main problem with comorbid patients is that more than one CIG (one for each disease) are executed on 
them, and dangerous interactions between (the effects of) actions from different CIGs may arise.  This 
sets up the need of developing ways of analysing and merging multiple single disease interventions to 
provide professionals' assistance to comorbid patients [4]. The development of these methods has been 
identified as one of the “grand challenges” for clinical decision support [5]. Since the early 2010's, the 
treatment of comorbidities has become a “hot” topic in the area of Medical Informatics, leading to 
innovative Artificial Intelligence architectures and methodologies (i) to detect interactions, or to (ii) 
manage them and “merge” the CIGs. However, GLARE-SSCPM (GLARE Support System for 
Comorbid Patient Management) is the first comprehensive framework supporting in an integrated and 
physician-friendly way both (i) and (ii) tasks.  
 
1 Published in IEEE Intelligent Systems. See https://doi.org/10.1109/MIS.2018.2886697  
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GLARE-SSCPM: General Architecture and Behavior of the System 
GLARE-SSCPM is an extension of GLARE (GuideLine Acquisition Representation and Execution, 
[6]), a well-known CIG framework. GLARE is the result of a long-term cooperation between the 
University of Eastern Piedmont and the San Giovanni hospital, started in 1997. The framework 
provides a formalism to represent CIGs, a tool to acquire them, a mechanism to execute a CIG on a 
determinate patient using patient’s data. Both the acquisition and the execution processes are supported 
by a graphic interface (GUI). In particular, GLARE acquisition tool adopts different types of syntactic 
and semantic facilities to support physicians in the explication of medical knowledge in the guidelines 
[7]. In GLARE, CIGs are represented as conditional and hierarchical graphs, whose nodes represent 
actions or decisions and whose arcs model the control flow relations and the temporal constraints 
between them (see examples in the following). GLARE distinguishes between atomic actions (simple 
steps in a CIG) and composite actions (plans), which are defined in terms of their components (thus 
supporting the definition of CIGs at different levels of abstraction). Atomic actions can be: work 
actions (a procedure which must be executed), pharmacological actions (a drug to be administered), 
query actions (retrieval of information from the clinical record/examinations) or decisions (choice 
among different alternatives). GLARE also adopt advanced Artificial Intelligence techniques to 
support challenging tasks such as temporal reasoning, cost-benefit analysis (for decision support), 
model-based verification [8]. Additionally, GLARE also exploits a Knowledge Manager, i.e., a module 
coping with additional (CIG-independent) medical knowledge [9]. It adopts an OWL ontological 
model developed in collaboration with expert physicians, using Protégé as main instrument and 
integrating part of the SNOMED CT and ACT ontologies. Each action in GLARE can be associated 
with one or more elements of the ontological model describing, for instance, its effects or intentions 
(part of the model useful for this paper will be detailed in the following). Moreover, the Knowledge 
Manager module is provided with standard OWL reasoners providing inferences. 
 
The first step in the extension of GLARE to cope with comorbidities was the identification of the 
different tasks to be solved.  In strict cooperation with the physicians in our team, we identified the 
following tasks: 
(1) The detection of interactions occurring between CIGs 
(2) The management of the interactions 
(3) The final merging of the CIGs 
We have separately discussed in technical detail our techniques to cope with each task independently 
of the others in previous publications, mostly in conference papers (interaction detection [9], 
interaction management [10], conciliation [11] and temporal reasoning for comorbidities [12], [13]). 
Notably, to cope with the medical problem, several advances with respect to the AI state of the art 
were achieved, such as the treatment of complex – and not explored yet – temporal issues [13], and an 
innovative approach to conditional plan merging [11].  
 
The second step, and first major contribution of this paper, is the definition of the intended behaviour 
of our overall approach, i.e., what are the facilities it should provide to physicians, and what is its 
intended interaction with them. As we will see in the comparison section, no current ICT approach 
copes with tasks 1-3 above together, and the large majority of them propose black-boxes tools. As 
regards interaction detection, such tools provide as output all the possible interactions between all the 
possible actions in the input CIGs. As regards management and merge (tasks 2 and 3 above), given a 
set of patient’s data and CIGs to be executed, they automatically return a “merge” of the CIGs. Our 20-
year experience of cooperation with physicians suggests that, although such approaches might present 
valuable Computer Science contributions, they are not likely to be used in the clinical practice. Indeed, 
physicians are the ultimate responsible of the health of their patients, and cannot delegate such a 
responsibility to a “black-box” fully automatic tool.  ICT tools must support physicians, not taking 
their place. Together with physicians, we have identified a flexible interaction between ICT support 
and physicians, based on the “focus, hypothesize and test” modality below.  
In our proposal, in a session of work on a comorbid patient, a physician can first (task 1; Interaction 
Detection) use GLARE-SSCPM to focus on the parts of the CIGs that are relevant to the current status 
of the patient, and use GLARE-SSCPM to find the possible interactions (if any) between the focused 
actions. A domain-independent knowledge base is used by GLARE-SSCPM, as well as temporal 
reasoning, to determine just those interactions that can effectively occur in time. Then (task 2; 
Interaction Management) a management for each interaction (if needed) can be chosen. GLARE-
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SSCPM provides a wide set of alternative management options, and a way to physicians to simulate 
the effects of applying the chosen managements (“what if” analysis). Once physicians have chosen a 
set of managements (one for each “undesirable” interaction), GLARE-SSCPM provides them (task 3; 
CIG Conciliation) a way of automatically checking the consistency of the given solution, and a “local 
merge” of the CIGs, implementing all the management options. Notably, if there is an inconsistency 
(i.e., the “solution” is unfeasible) or if physicians want to check alternative solutions, GLARE-SSCPM 
supports them in a sort of “hypothesize and test” loop: new management options can be selected, and a 
new “local merge” can be obtained. The final solution is then a local adaptation of the CIGs, that can 
be executed by GLARE. Then, an outer loop (the “focusing” loop) is supported: physicians can move 
the focus (to the next part of the CIGs) and restart the process (interaction detection, management, and 
CIG “merge”). 
 
Third, in this paper we first propose the overall architecture of GLARE-SSCPM (see Figure 1). 
Notably, there is a module for each one of the tasks below, plus a specialized temporal reasoner, and 
the communications between the different components implement the focusing and the hypothesize 
and test loops described above.  
GLARE-SSCPM: Main Components 
Running example. We consider a comorbid patient affected by Venous Thrombosis (VT) and Peptic 
Ulcer (PU). In Figure 2.a, we show a screenshot of the GUI of GLARE-SSCPM during the interaction 
Figure 1 Architecture of GLARE-SSCPM. 
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analysis.  Both the CIGs are simplified versions of the ones provided by the British National Institute 
for Health and Care Excellence (www.nice.org.uk). The upper rectangle in Figure 2.a shows the two 
original CIGs at the highest level of detail; the lower rectangle shows the expansion of H. pylori 
eradication (from PU) and of Pharmacological intervention (from VT), after a “focusing” action and 
the detection of the interactions, plus the management of one of them (see above). Figure 2.b shows 
the management of another interaction and 2.c shows the two CIGs after the final merging (for the 
sake of space, only a part of the GUI screenshots is shown). 
Interaction Detection 
Usually, CIGs may consist of hundreds of nodes (representing actions). Thus, the physician’s 
knowledge is fundamental to focus the analysis only on the interactions that are relevant for the patient 
at hand. GLARE-SSCPM Interaction Detection module [9] provides flexible and interactive focusing 
tool allowing physicians to navigate through the different abstraction levels, thus supporting the 
natural methodology they adopt to cope with CIG analysis. Specifically, GLARE-SSCPM interaction 
detection algorithm maintains in a tree data structure, called navigation tree, the history of the focusing 
process, supporting both the addition of new CIG focuses, and the rollback to upper focuses. Each 
node of the tree consists of three main components: two pairs <CIG1, focus1>, <CIG2, focus2> 
determining the desired level of abstraction and the focused actions, and an interaction component, in 
Figure 2 Different phases of CIG merging with GLARE-SSCPM. Legend: blue nodes are work actions, green query actions, 
yellow decisions and red composite actions. 
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which, for each pair <Ai,Aj> of actions (Ai ∈ focus1, Aj ∈ focus2), the detected interactions are pointed 
out. In our example, the physician decided, starting from the CIGs in the top of Figure 2.a (i.e., the root 
of the navigation tree), to focus on the composite action “helicobacter pylori eradication” (HPEr; in 
PU) and the composite action “pharmacological intervention” (PI; in VT) (i.e., <CIG1, focus1>, 
<CIG2, focus2> instantiates to<PU, {HPEr}>,<VT, {PI}>) . Then, our system creates a node in the 
navigation tree, shown in the bottom of the figure, in which the focused actions HPEr and PI are 
expanded, accordingly to the hierarchical representation in GLARE’s PU and VT CIGs. Specifically, 
HPEr is expanded with the choice between clarithromycin and amoxicillin or metronidazole and 
amoxicillin, while the PI is expanded with the choice between warfarin and fondaparinux therapies. 
Once the actions of interest are identified though focusing, physicians may perform interaction 
detection on them. The interaction detection is automatic: GLARE-SSCPM exploits the knowledge 
base and the OWL reasoner to retrieve all the interactions between the intentions, effects and drugs 
prescribed (in case of pharmacological actions) of the focused actions.  
In our example, we suppose that the physician focuses on the detection of interactions between 
amoxicillin (two alternative occurrences, A1 and A2 in Fig.2a) and warfarin (W) or fondaparinux (F) 
(formally, the focus1 instantiates to<PU, {A1,A2}> and focus2 to <VT, {W,F}>). S/he selects the 
actions from the GUI and asks to the system to perform interaction detection (i.e., the pairs <Ai,Aj> of 
actions (Ai ∈ focus1, Aj ∈ focus2 are: {<A1,W>,<A1,F>, <A2,W>,<A2,F>}). 
In short, the Knowledge Base (see Figure 1) contains the knowledge that amoxicillin has antiplatelet 
effects, and that warfarin has anticoagulant effects. Both effects cause an increase in the risk of 
bleedings. As a consequence, through the application of a set of Semantic Web Rules (SWRLs), the 
knowledge manager infers that an interaction between them is possible, leading to an increased risk of 
bleedings (see in the right part of the node, the interaction “W-A1: <ACTION: Warfarin therapy, 
SUBSTANCE: Warfarin, ACTION: Amoxicilin therapy, SUBSTANCE: Amoxicilin, CHANGES: risk 
of bleedings, MODALITY: increase>. The detection of other interactions is similar. 
 Interaction Management 
Once detected and analysed, interactions must be managed.  Management options are local changes to 
the CIGs, which make the original CIGs executable avoiding undesirable interactions and promoting 
desirable ones. Analysing the medical literature, we have identified the main interaction management 
operations adopted by physicians in the medical practice [10]:  
Safe Alternative: avoid an interaction by proposing alternative paths in the CIGs. 
Replanning: add new alternative actions with the same intentions of the original ones. 
Temporal Avoidance: avoid an interaction by imposing additional temporal constraints.  
Effect Monitoring: maintain the interaction, introducing a monitoring action to monitor the effects of 
the interaction itself.  
Dosage Adjustment: mitigate an interaction by changing drug dosage. 
Interaction Mitigation: mitigate an interaction through the introduction of a new action.  
Interaction Alignment: force the occurrence of a desired interaction, by imposing that specific paths 
are executed at specific times in the two CIGs. 
Intention Alignment: manage actions aiming to the same intention, by avoiding redundancy.  
We defined the instantiation of the above management operations through the composition of three 
basic reasoning techniques: 
(1) Backward Navigation (NAV), navigating backward the CIGs to find alternative paths leading to or 
avoiding a given interaction 
(2) Goal Based Planning (GBP), that, given some intentions, interactively builds a CIG achieving 
such intentions 
(3) Temporal reasoning (TR), providing (through the Temporal Module) different temporal reasoning 
facilities, such as, e.g., when to execute actions to temporally avoid a given interaction.   
Given an interaction, our Interaction Management module [10] provides physicians with the 
possibility of choosing the most appropriate management (option), and show how the original CIGs are 
modified by its application to the CIGs. 
In our example, we suppose that the user-physician chooses to apply the safe alternative management 
option to the interactions “F-A1” and “F-A2”. The resulting constraints (blue-label elements) are 
shown in the rectangle “Managements” of the bottom element in Figure 2.a. Basically, they avoid the 
concurrent execution of the paths containing the amoxicillin therapy and the Fondaparinux one. For the 
interactions “W-A1” and “W-A2”, we suppose that the user-physician has chosen the replanning 
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management option. The system drove physicians, through a GUI, in the planning of a part of CIG 
having the same intention of the Warfarin therapy (i.e., to avoid thrombi). The result is a plan 
consisting of two composite actions, retrieved from the knowledge model, prescribing the 
acetylsalicylic acid and omeprazole therapies (see Figure 2.b). The system automatically added a 
decision before the warfarin therapy and, as other alternative, the acetylsalicylic acid therapy. Finally, 
it adds two constrains stating that amoxicillin and warfarin therapies cannot be executed together.  
CIG Conciliation 
Once the interactions have been identified, and managed in isolation, the simple union of the original 
CIGs with the applied managements is not yet an executable CIG. Two aspects must be considered: (i) 
the management options lead to changes to the original CIGs that are “locally” consistent, but possibly 
not consistent with each other, and (ii) the conjunctive application of multiple management options can 
lead to the introduction of additional constraints. For these reasons, a final “merging” step is required. 
This is the goal of the CIG Conciliation module [11], which provides as output a “merged” CIG 
executable by GLARE.  
We base our approach to CIG conciliation on the CSP (Constraint Satisfaction Problem) framework. 
The process is automatic, and it is divided into three phases. First, the system derives a CSP (CSPorig) 
from the focused part of the original CIGs, the execution log (where available) and the managements. 
After that, CSPorig is propagated. During the propagation process, the consistency of the problem is 
checked and new constraints are found. If CSPorig is consistent, a new (propagated) CSP is obtained, 
called CSPprop. Finally, our system transforms back it in a CIG executable in GLARE. Otherwise, if 
CSPorig is not consistent, an execution in which the interactions are managed as chosen is not possible 
and the user is driven in the changing of the chosen managements (going back to the management 
phase).  
The result of the conciliation phase of our example is shown in Figure 2.c. The resulting CIG is 
consistent, but two additional constraints are added by the conciliation phase (red-label elements). In 
particular, the first one shows that in case helicobacter pylori eradication is required for PU, 
fondaparinux therapy cannot be executed. This constraint, even if obvious, is important in case 
physician has already started the anticoagulant therapy when helicobacter pylori test results positive: in 
this case, an exception is thrown and a further management is required. On the other hand, the second 
added constraint states that, in case the patient results positive to helicobacter pylori evaluation, the 
path of acetylsalicylic acid therapy must be chosen in the new decision added to the CIGs. 
 Temporal Module 
Temporal constraints are an essential ingredient of CIGs, and temporal reasoning is necessary for 
many tasks in the field of CIGs [14]. For instance, during interaction detection, temporal reasoning 
must be used to check whether possible interaction can actually occur or not, given the temporal 
information available in the knowledge base (temporal constraints between actions and the variations 
they cause) and in the CIGs (temporal constraints between actions), and the time of execution of 
previous actions on the patient. We have chosen to devote a specific module, the Temporal module 
[13] in Figure 1, operating as a knowledge server, to cope with temporal constraints and temporal 
reasoning.  Our treatment of temporal constraints is grounded on the STP framework, that we have 
extended along several directions to support several facilities, such as checking whether two actions 
may temporally interact, or determining execution times of some future actions to avoid some 
interactions. As an example, the amoxicillin therapy for PU lasts 10-14 days. Suppose that the 
physician has started five days ago the amoxicillin treatment A1 and decides to apply temporal 
avoidance to avoid the A1-W interaction. Thus, the Temporal Module is invoked, to suggest a starting 
point for W that certainly avoids the overlap between the interacting effects of A1 and of W. In this 
simple example, the effects hold only during the action executions, thus, after temporal reasoning, the 
system suggests to start W after the end of A1. To certainly avoid the overlap, it considers the 
maximum duration of A1, suggesting to start W after 9 days from now. 
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Related Work and Comparisons 
In the last years, several AI approaches have been developed coping with the issue of managing 
comorbid patients (see the survey [15]). Previous approaches did either cope with (i) interaction 
detection, or with (ii) interaction management and CIG “merge”.  
(i) Interaction detection. Few approaches focused on interaction detection. The most relevant 
approach in such an area is the one in [16]. It provides a CIG and domain-independent conceptual 
model for medical actions and reasoning forms operating on it. Moreover, in such a work general rules 
are proposed to identify different types of interactions on the basis of such a knowledge.  
(ii) interaction management and CIG “merge”. Several approaches have been devoted to the 
generation of integrated CIGs. It is possible to distinguish between the approaches aiming at achieving 
“conservative” CIGs, and those that do not. The approach in [17], for instance, belongs to the latter 
category. It builds ad-hoc CIGs from scratch, using an agent-based approach. Agents with hierarchical 
planning capabilities represent experts in the treatment of specific diseases. The CIG coping with the 
comorbidity is obtained through the coordination of all the agents. On the other hand, most of the 
approaches in literature (included GLARE-SSCPM) adopt more conservative techniques, attempting to 
merge existing CIGs. We follow such a mainstream, since, in the real medical practice, physician need 
to follow as much as possible evidence-based recommendations, such as the ones proposed in the 
original CIGs. Within such approaches, the one in [18] uses constraint logic programming (CLP). A 
CLP is derived from the CIGs, the interactions and their managements. Finally, a mitigation algorithm 
is applied to obtain the merged CIG. Riaño and Collado [4] propose a model-based approach for the 
combination of treatments. They model treatments as oriented graphs composed by decisions and 
actions. With the help of physicians, they define a set of operators to merge decisions or actions. The 
combination of the original CIGs is obtained through the application of the operators.  
In our opinion, GLARE-SSCPM advances the state of the art to several respects. 
(1) Integration. GLARE-SSCPM is the first system that manages, in an integrated way, both aspects 
(i) and (ii) above. 
(2) User-friendliness and usability.  As discussed in the introduction, the main goal of GLARE and 
GLARE-SSCPM is to support physicians, not to substitute them. This aspect clearly distinguishes 
GLARE-SSCPM by the aforementioned approaches in the literature, which mostly work in a “black-
box” fashion. In particular, current approaches are geared towards the detection of the management of 
all the possible interactions between CIGs. However, each CIG may consist of hundreds of actions 
and\or alternative paths of actions, and the treatment of each possible interaction (between each pair of 
actions) would lead to a quadratic number of interactions, most of which are totally useless for the 
treatment of the patient at hand, either because the physician knows that certain actions\path are not 
applicable to the specific patient, or because the interaction cannot occur in time. On the other hand, 
we propose focusing facilities, so that physicians can focus the detection and management only on the 
“relevant” parts of the CIGs. Additionally, as regards CIG merge, current approaches assume that a 
“table” with the possible interactions and their managements is defined a priori by physicians. Given 
such a “table”, they operate in a black-box fashion, directly providing as output the “merged” CIG 
managing all the interactions. This approach looks not acceptable for physicians, since the 
management of each given interaction usually depends on the specific patient and context of execution. 
A further improvement is that GLARE-SSCPM supports temporal constraints and temporal reasoning. 
We have already defined and published the different components of GLARE-SSCPM [8]–[11]. 
However, this paper first presents: (i) the definition of the behaviour of the whole system, i.e., of the 
way in which the system support physicians in a session of work on a comorbid patient, through a 
“focusing, hypothesize and test” interaction; (ii) the definition of an integrated architecture to achieve 
such a support. Notably, to achieve such goals, additional contributions have been provided, such as 
(iii) GLARE formalism and (iv) the Temporal module high-level formalism have been extended to be 
able to model also some constraints provided by the CIG conciliation module (i.e., by the CSP); (v) the 
CIG conciliation module has been modified to be able to operate also on limited parts of the input 
CIGs (i.e., on the focuses provided by the Interaction Detection module).  
Implementation and experimental evaluation 
Starting from 1997, a prototype of GLARE has been implemented in JAVA, and extensively and 
successfully tested by the physicians of the San Giovanni Hospital to cope with different phenomena, 
including bladder cancer, reflux esophagitis, heart failure, and ischemic stroke. Since from one side 
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there is not a regional patient Electronic Medical Record and from the other side the hospitals have not 
financed yet a full engineered version of our system, GLARE has not achieved yet the status of 
“medical device”, so that it has not been used yet in the clinical practice. However, it has been 
extensively used for education of medical students and healthcare practitioners. GLARE-SSCPM has 
been prototypically implemented in Java and OWL. A preliminary version of GLARE-SSCPM has 
been already tested in the training of healthcare practitioners in the context of emergency medicine, to 
cope with poly-trauma, within the ROPHS (Report on the Piedmont Health System) project. The 
interactivity of GLARE-SSCPM and its capability of supporting “focus, hypothesize and test” sessions 
of work has been crucial in the success of our system, which has facilitated the learning process of a 
cohort of about twenty healthcare professionals. We foresee to provide more extensive evaluations in 
the education context, with a comparative analysis of the skills acquired with and without the adoption 
of GLARE-SSCPM. GLARE-SSCPM has also been tested by physicians in our group on a set of toy 
comorbidity examples, on simulated patients. Such preliminary tests have shown the our focusing and 
interaction detection facilities and “hypothesize and test” support actually facilitate physicians in the 
management of comorbidities. However, more extensive and systematic evaluations are needed, and 
are the goal of our future work.  
Conclusions  
The treatment of comorbidities constitutes a challenging problem, since it involves the detection and 
management of the possible interactions between CIGs, and a final conciliation of the selected 
management options. In this paper, for the first time, we show the integrated architecture of GLARE-
SSCPM, describing how different modules interacts to the overall goal of supporting physicians in the 
management of the above tasks, to cope with comorbid patients. GLARE-SSCPM constitutes a 
significant advance over the state of the art.  
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